ARTÍCULO

Recommendations for acquisition, interpretation and reporting of whole body low dose CT in patients with multiple myeloma and other plasma cell disorders: a report of the IMWG Bone Working Group

Autores: Moulopoulos, L. A. (Autor de correspondencia); Koutoulidis, V. ; Hillengass, J.; Zamagni, E.; Aquerreta Beola, Jesús Dámaso; Roche, C. L.; Lentzsch, S. ; Moreau, P.; Cavo, M.; San Miguel Izquierdo, Jesús Fernando; Dimopoulos, M. A. ; Rajkumar, S. V.; Durie, B. G. M.; Terpos, E.; Delorme, S.
Título de la revista: BLOOD CANCER JOURNAL
ISSN: 2044-5385
Volumen: 8
Número: 10
Páginas: 95
Fecha de publicación: 2018
Lugar: WOS
Resumen:
Whole Body Low Dose CT (WBLDCT) has important advantages as a first-line imaging modality for bone disease assessment in patients with plasma cell disorders and has been included in the 2014 International Myeloma Working Group (IMWG) criteria for multiple myeloma (MM) definition. Nevertheless, standardization guidelines for the optimal use of WBLDCT in MM patients are still lacking, preventing its more widespread use, both in daily practice and clinical trials. The aim of this report by the Bone Group of the IMWG is to provide practical recommendations for the acquisition, interpretation and reporting of WBLDCT in patients with multiple myeloma and other plasma cell disorders.